Asia's Top 10 Freeze Dried Vaccine Brand List

April 10, 2024

Freeze dried vaccines are a game-changer in the medical field. They provide a longer shelf life, making them easier to transport and store in remote areas. This technology eliminates the need for constant refrigeration, ensuring vaccines remain potent. Freeze dried vaccines are cost-effective and crucial in reaching underserved populations.

AstraZeneca
Bharat Biotech
Changchun Zhuoyi Biological Co., Ltd
Serum Institute of India
Sinovac Biotech
Sinopharm
Moderna

AstraZeneca

Establishment time : 6 April 1999

website : www.astrazeneca.com

Main Product : Pharmaceuticals, vaccines

Company Profile

AstraZeneca is a global biopharmaceutical company focused on developing innovative medicines to address unmet medical needs. With a strong pipeline of products and a commitment to research and development, AstraZeneca strives to improve the lives of patients worldwide.

Bharat Biotech

Establishment time : Bharat Biotech was founded in 1996 with a focus on developing innovative vaccines.

website :

Main Product : Bharat Biotech is known for its cutting-edge research and development capabilities in the field of biotechnology.

Company Profile

Bharat Biotech faces competition from global pharmaceutical companies, but continues to innovate and expand its product portfolio.

Changchun Zhuoyi Biological Co., Ltd

Establishment time : 2005

website : www1.zhuoyi-bio.com

Main Product : Human Rabies Vaccine,Rabies Prevention ,Freeze-dried Human Rabies Vaccine ,Rabies Vaccine,Human Rabies Vaccination,Human Rabies Vaccine and Infant

Company Profile

Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.

Serum Institute of India

Establishment time : Founded in 1966, Serum Institute of India is a global leader in vaccine manufacturing.

website :

Main Product : With a large production capacity, Serum Institute of India supplies vaccines to markets worldwide.

Company Profile

With a strong reputation for reliability and efficacy, Serum Institute of India remains at the forefront of vaccine development and distribution.

Sinovac Biotech

Establishment time : Sinovac Biotech is a leading biopharmaceutical company based in China.

website :

Main Product : Sinovac Biotech is known for its COVID-19 vaccine, which has been widely used in vaccination campaigns around the world.

Company Profile

Sinovac Biotech's mission is to provide safe and effective vaccines to protect public health worldwide.

Sinopharm

Establishment time : Sinopharm Group Co., Ltd. is a leading Chinese healthcare company founded in 1998.

website :

Main Product : With over 100,000 employees, Sinopharm is one of the largest healthcare companies in China.

Company Profile

For more information about Sinopharm, visit their website at www.sinopharm.com.

Moderna

Establishment time : Moderna is a biotechnology company focused on developing mRNA-based vaccines and therapeutics.

website :

Main Product : Moderna's main products include mRNA-based vaccines for infectious diseases and personalized cancer therapies.

Company Profile

Moderna has gained attention for its rapid development of a COVID-19 vaccine during the global pandemic.

Author:

Mr. Simba Li

E-mail:

lixuejian@zy-bio.cn

Phone/WhatsApp:

+86 18946525326